Clinical Trial Update: Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission [Phase 3]

View source ↗

Summary

A completed Phase 3 trial sponsored by the Children's Oncology Group assessed adherence to mercaptopurine therapy in younger children with acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Mercaptopurine (Mercaptopurine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED